25 April 2025 -- Durham, NC and Männedorf, Switzerland -- BioSkryb Genomics and Tecan Group today introduced a high-throughput single-cell workflow, combining BioSkryb’s 384-well format of the ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit with the Uno Single Cell Dispenser™, provided by Tecan.

24 April 2025 -- Eschborn, Germany -- AnalytiChem, manufacturer of specialized laboratory equipment, reagents and consumables, has introduced Redipor ready-to-use culture media as an AnalytiChem branded product line globally.

22 April 2025 -- Bubendorf, Switzerland -- CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce that its Shanghai facility has successfully obtained its first Drug Manufacturing License (DML) from China’s National Medical Products Administration (NMPA).

14 April 2025 -- Cambridge, UK and Massachusetts, US -- Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery system, today announced the addition of a new membrane protein workflow to its system.

11 April 2025 -- Birmingham, UK -- In the latest episode of the Aston Originals podcast What is a membrane?, Dr Emma Shepherd, Dr Dominic Mosses and Dr David Jenkins join host Dr Matt Derry to explain the workings and potential of Aston University’s Quantum X bio printer.

8 April 2025 -- Osaka, Japan -- Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President & CEO: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) presents new European data from its largest real-world evidence study of Fetroja®/Fetcroja® (cefiderocol), an innovative siderophore cephalosporin at the 35th Congress of the European Society of Clinical Microbiology and Infectious Diseases in Vienna on 11th-15th April 2025.

7 April 2025 -- California, US -- Shockwave Medical, Inc., part of Johnson & Johnson MedTech and a global leader in the field of circulatory restoration, announced it has initiated its pivotal FORWARD CAD investigational device exemption (IDE) study. Investigators in the study will assess the safety and effectiveness of the Shockwave Javelin Coronary IVL Catheter for the treatment of calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting.

2 April 2025 -- Melbourne, Australia -- Neurizon Therapeutics Limited, a clinical-stage biotech company dedicated to advancing treatments for neurodegenerative diseases, is pleased to advise that results from an independent study undertaken in collaboration with Tessara Therapeutics will be presented by the group’s Principal Scientist and Alzheimer’s Disease expert, Dr Mark Greenough at the AD/PD 2025 Advances in Sciences & Therapy conference on April 2nd to 3rd.

2 April 2025 -- Cambridge, UK -- 4basebio, a company which develops and commercialises the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today announced that it has received Good Manufacturing Practice (GMP) certification from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).

2 April 2025 -- Stockholm, Sweden -- Sobi in the UK today announced that the National Institute for Health and Care Excellence (NICE) has issued its Final Guidance in England and Wales recommending the use of Altuvoct (efanesoctocog alfa).  The high-sustained factor VIII replacement therapy will now be available for treating and preventing bleeding episodes in people with severe haemophilia A aged 2 years and over. 

2 April 2025 -- Florida, US -- Bend Bioscience, a leading innovation, science, and pharmaceutical services partner, today announced the addition of a commercial-scale spray dryer and a Gerteis dry granulation system at its 120,000-square-foot facility in Gainesville, Georgia.

1 April 2025 -- Shanghai, China -- ChinaBio Partnering Forum, the largest and most productive life science partnering event in China, returns in 2025 with a hybrid format to facilitate global cross-border collaborations. The event will take place in person on April 23-24 at the Kerry Hotel Pudong in Shanghai, followed by a virtual edition on April 29-30, leveraging partneringONE™ to maximize engagement and dealmaking opportunities.